638 related articles for article (PubMed ID: 21300154)
1. Nucleic acid aptamers targeting cell-surface proteins.
Dua P; Kim S; Lee DK
Methods; 2011 Jun; 54(2):215-25. PubMed ID: 21300154
[TBL] [Abstract][Full Text] [Related]
2. Complex target SELEX.
Shamah SM; Healy JM; Cload ST
Acc Chem Res; 2008 Jan; 41(1):130-8. PubMed ID: 18193823
[TBL] [Abstract][Full Text] [Related]
3. Advances in SELEX and application of aptamers in the central nervous system.
Yang Y; Yang D; Schluesener HJ; Zhang Z
Biomol Eng; 2007 Dec; 24(6):583-92. PubMed ID: 17681489
[TBL] [Abstract][Full Text] [Related]
4. SELEX--a (r)evolutionary method to generate high-affinity nucleic acid ligands.
Stoltenburg R; Reinemann C; Strehlitz B
Biomol Eng; 2007 Oct; 24(4):381-403. PubMed ID: 17627883
[TBL] [Abstract][Full Text] [Related]
5. The application of aptamers in cancer research: an up-to-date review.
Hu M; Zhang K
Future Oncol; 2013 Mar; 9(3):369-76. PubMed ID: 23469972
[TBL] [Abstract][Full Text] [Related]
6. Application of aptamers for targeted therapeutics.
Ray P; Viles KD; Soule EE; Woodruff RS
Arch Immunol Ther Exp (Warsz); 2013 Aug; 61(4):255-71. PubMed ID: 23563807
[TBL] [Abstract][Full Text] [Related]
7. Aptamers and SELEX in Chemistry & Biology.
Famulok M; Mayer G
Chem Biol; 2014 Sep; 21(9):1055-8. PubMed ID: 25237853
[TBL] [Abstract][Full Text] [Related]
8. Aptamer-drug conjugation for targeted tumor cell therapy.
Donovan MJ; Meng L; Chen T; Zhang Y; Sefah K; Tan W
Methods Mol Biol; 2011; 764():141-52. PubMed ID: 21748638
[TBL] [Abstract][Full Text] [Related]
9. Nanotechnology and aptamers: applications in drug delivery.
Levy-Nissenbaum E; Radovic-Moreno AF; Wang AZ; Langer R; Farokhzad OC
Trends Biotechnol; 2008 Aug; 26(8):442-9. PubMed ID: 18571753
[TBL] [Abstract][Full Text] [Related]
10. [Aptamers in clinical diagnostics].
Szpechciński A; Grzanka A
Postepy Biochem; 2006; 52(3):260-70. PubMed ID: 17201061
[TBL] [Abstract][Full Text] [Related]
11. Combining SELEX and the yeast three-hybrid system for in vivo selection and classification of RNA aptamers.
König J; Julius C; Baumann S; Homann M; Göringer HU; Feldbrügge M
RNA; 2007 Apr; 13(4):614-22. PubMed ID: 17283213
[TBL] [Abstract][Full Text] [Related]
12. Nucleic acid-based aptamers as promising therapeutics in neoplastic diseases.
Cerchia L; de Franciscis V
Methods Mol Biol; 2007; 361():187-200. PubMed ID: 17172712
[TBL] [Abstract][Full Text] [Related]
13. Selection of RNA aptamers against recombinant transforming growth factor-beta type III receptor displayed on cell surface.
Ohuchi SP; Ohtsu T; Nakamura Y
Biochimie; 2006 Jul; 88(7):897-904. PubMed ID: 16540230
[TBL] [Abstract][Full Text] [Related]
14. Aptamers: new arrows to target dendritic cells.
Ganji A; Varasteh A; Sankian M
J Drug Target; 2016; 24(1):1-12. PubMed ID: 25950603
[TBL] [Abstract][Full Text] [Related]
15. Disease-specific biomarker discovery by aptamers.
Ulrich H; Wrenger C
Cytometry A; 2009 Sep; 75(9):727-33. PubMed ID: 19565638
[TBL] [Abstract][Full Text] [Related]
16. The development and testing of aptamers for cancer.
Barbas AS; White RR
Curr Opin Investig Drugs; 2009 Jun; 10(6):572-8. PubMed ID: 19513946
[TBL] [Abstract][Full Text] [Related]
17. Targeting cancer cells with nucleic acid aptamers.
Cerchia L; de Franciscis V
Trends Biotechnol; 2010 Oct; 28(10):517-25. PubMed ID: 20719399
[TBL] [Abstract][Full Text] [Related]
18. Evolution of Complex Target SELEX to Identify Aptamers against Mammalian Cell-Surface Antigens.
Mallikaratchy P
Molecules; 2017 Jan; 22(2):. PubMed ID: 28146093
[TBL] [Abstract][Full Text] [Related]
19. [Screening and characterization of DNA aptamers with hTNF-alpha binding and neutralizing activity].
Guo KT; Yan XR; Huang GJ; Xu CX; Chai YS; Zhang ZQ
Sheng Wu Gong Cheng Xue Bao; 2003 Nov; 19(6):730-3. PubMed ID: 15971588
[TBL] [Abstract][Full Text] [Related]
20. Surface plasmon resonance investigation of RNA aptamer-RNA ligand interactions.
Di Primo C; Dausse E; Toulmé JJ
Methods Mol Biol; 2011; 764():279-300. PubMed ID: 21748648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
